Swiss National Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.2M | Buy |
1,115,200
+50,100
| +5% | +$1.81M | 0.02% | 481 |
|
|
2025
Q1 | $33.2M | Sell |
1,065,100
-11,000
| -1% | -$342K | 0.02% | 506 |
|
|
2024
Q4 | $27.5M | Sell |
1,076,100
-64,500
| -6% | -$1.65M | 0.02% | 564 |
|
|
2024
Q3 | $32.3M | Buy |
1,140,600
+17,000
| +2% | +$481K | 0.02% | 532 |
|
|
2024
Q2 | $29.6M | Sell |
1,123,600
-13,400
| -1% | -$353K | 0.02% | 532 |
|
|
2024
Q1 | $34.5M | Sell |
1,137,000
-56,200
| -5% | -$1.71M | 0.02% | 521 |
|
|
2023
Q4 | $33.5M | Sell |
1,193,200
-32,300
| -3% | -$907K | 0.02% | 526 |
|
|
2023
Q3 | $33.3M | Sell |
1,225,500
-134,800
| -10% | -$3.66M | 0.03% | 517 |
|
|
2023
Q2 | $41.8M | Sell |
1,360,300
-40,100
| -3% | -$1.23M | 0.03% | 488 |
|
|
2023
Q1 | $50.5M | Sell |
1,400,400
-20,900
| -1% | -$753K | 0.03% | 449 |
|
|
2022
Q4 | $56.2M | Sell |
1,421,300
-87,910
| -6% | -$3.47M | 0.04% | 411 |
|
|
2022
Q3 | $60.6M | Buy |
1,509,210
+6,700
| +0.4% | +$269K | 0.04% | 380 |
|
|
2022
Q2 | $63.2M | Buy |
1,502,510
+14,200
| +1% | +$597K | 0.04% | 396 |
|
|
2022
Q1 | $58M | Buy |
1,488,310
+189,800
| +15% | +$7.39M | 0.03% | 474 |
|
|
2021
Q4 | $51.7M | Buy |
1,298,510
+599,500
| +86% | +$23.9M | 0.03% | 488 |
|
|
2021
Q3 | $25.3M | Sell |
699,010
-15,500
| -2% | -$560K | 0.02% | 628 |
|
|
2021
Q2 | $29.3M | Buy |
714,510
+42,810
| +6% | +$1.75M | 0.02% | 617 |
|
|
2021
Q1 | $29.3M | Buy |
671,700
+242,200
| +56% | +$10.6M | 0.02% | 604 |
|
|
2020
Q4 | $21.5M | Buy |
+429,500
| New | +$21.5M | 0.02% | 642 |
|